Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GRWC Grow Capital	$0.20	$0.24	$0.01 ▼ $0.42	$30.36M	26.86	304 shs	N/A
GRWG GrowGeneration	$1.70 -4.0%	$1.20	$0.82 ▼ $2.27	$101.61M	3	962,810 shs	366,364 shs
NMUS Nemus Bioscience		$0.00	$0.05 ▼ $0.74	$87.04M	-0.04	377,395 shs	1.00 million shs
XXII 22nd Century Group	$1.75 -2.8%	$4.07	$1.72 ▼ $1,571.13	$6.62M	1.81	269,021 shs	140,032 shs

5G Stocks: The Path Forward is Profitable

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GRWC Grow Capital	0.00%	0.00%	0.00%	0.00%	+100.00%
GRWG GrowGeneration	0.00%	-3.95%	+73.75%	+60.38%	-12.82%
NMUS Nemus Bioscience	0.00%	0.00%	0.00%	0.00%	0.00%
XXII 22nd Century Group	0.00%	-11.17%	-29.15%	-89.96%	-99.82%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
GRWC Grow Capital	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GRWG GrowGeneration	3.2838 of 5 stars	3.5	5.0	0.0	0.0	3.3	0.0	1.3
NMUS Nemus Bioscience	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
XXII 22nd Century Group	0.5446 of 5 stars	0.0	4.0	0.0	0.0	2.0	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GRWC Grow Capital	0.00	N/A	N/A	N/A
GRWG GrowGeneration	3.00	Buy	$2.50	47.06% Upside
NMUS Nemus Bioscience	0.00	N/A	N/A	N/A
XXII 22nd Century Group	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest GRWC, GRWG, NMUS, and XXII Analyst Ratings

Date	Company	Brokerage	Action	Rating
8/30/2025	XXII 22nd Century Group	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (E) ➝ Sell (E+)
8/14/2025	XXII 22nd Century Group	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (E+) ➝ Sell (E)
7/29/2025	XXII 22nd Century Group	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (E) ➝ Sell (E+)
7/12/2025	XXII 22nd Century Group	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (E+) ➝ Sell (E)
6/27/2025	XXII 22nd Century Group	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (E) ➝ Sell (E+)
6/11/2025	XXII 22nd Century Group	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (E+) ➝ Sell (E)

(Data available from 9/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GRWC Grow Capital	$2.66M	11.41	N/A	N/A	N/A	∞
GRWG GrowGeneration	$188.87M	0.54	N/A	N/A	$2.03 per share	0.84
NMUS Nemus Bioscience	N/A	N/A	N/A	N/A	($0.12) per share	N/A
XXII 22nd Century Group	$24.38M	0.27	N/A	N/A	$53.71 per share	0.03

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GRWC Grow Capital	-$1.30M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
GRWG GrowGeneration	-$49.51M	-$0.82	N/A	N/A	N/A	-29.84%	-34.92%	-24.04%	11/11/2025 (Estimated)
NMUS Nemus Bioscience	-$19.19M	N/A	0.00	N/A	N/A	N/A	N/A	-924.42%	N/A
XXII 22nd Century Group	-$15.16M	-$2,986.49	N/A	∞	N/A	-80.22%	-344.13%	-62.82%	11/12/2025 (Estimated)

Latest GRWC, GRWG, NMUS, and XXII Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/14/2025	Q2 2025	XXII 22nd Century Group	-$0.27	-$13.16	-$12.89	-$13.61	$5.44 million	$4.08 million
8/11/2025	Q2 2025	GRWG GrowGeneration	-$0.11	-$0.08	+$0.03	-$0.08	$40.96 million	$40.96 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
GRWC Grow Capital	N/A	N/A	N/A	N/A	N/A
GRWG GrowGeneration	N/A	N/A	N/A	N/A	N/A
NMUS Nemus Bioscience	N/A	N/A	N/A	N/A	N/A
XXII 22nd Century Group	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GRWC Grow Capital	N/A	N/A	N/A
GRWG GrowGeneration	N/A	4.00	2.47
NMUS Nemus Bioscience	N/A	0.12	0.12
XXII 22nd Century Group	N/A	0.77	0.61

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GRWC Grow Capital	N/A
GRWG GrowGeneration	36.02%
NMUS Nemus Bioscience	N/A
XXII 22nd Century Group	18.06%

Insider Ownership

Company	Insider Ownership
GRWC Grow Capital	43.90%
GRWG GrowGeneration	7.62%
NMUS Nemus Bioscience	2.70%
XXII 22nd Century Group	0.01%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GRWC Grow Capital	9	151.81 million	85.17 million	Not Optionable
GRWG GrowGeneration	690	59.77 million	55.22 million	Optionable
NMUS Nemus Bioscience	11	133.91 million	N/A	Not Optionable
XXII 22nd Century Group	80	3.78 million	3.78 million	Optionable

GRWC, GRWG, NMUS, and XXII Headlines

Recent News About These Companies

22nd Century Group (NASDAQ:XXII) Earns Sell (E+) Rating from Weiss Ratings

August 31 at 2:13 AM | americanbankingnews.com

Emerging Growth Research Releases Q2 2025 Update Report on 22nd Century Group

August 22, 2025 | newsfilecorp.comN

22nd Century Group, Inc (NASDAQ:XXII) Short Interest Update

August 22, 2025 | americanbankingnews.com

22nd Century Group, Inc.: 22nd Century CEO & Chairman Larry Firestone Provides Technology and Regulatory Update Letter to Stockholders

August 20, 2025 | finanznachrichten.de

22nd Century issues letter to shareholders

August 20, 2025 | msn.com

22nd Century CEO & Chairman Larry Firestone Provides Technology and Regulatory Update Letter to Stockholders

August 20, 2025 | globenewswire.com

22nd Century to Participate in the Emerging Growth Conference on August 20, 2025

August 18, 2025 | globenewswire.com

22nd Century Group Sales Drop 49 Percent

August 15, 2025 | theglobeandmail.com

22nd Century Group, Inc. (NASDAQ:XXII) Q2 2025 Earnings Call Transcript

August 15, 2025 | msn.com

22nd Century: Q2 Earnings Snapshot

August 14, 2025 | timesunion.comT

22nd Century Group, Inc. (XXII) Q2 2025 Earnings Call Transcript

August 14, 2025 | seekingalpha.com

22nd Century Group Reports Second Quarter 2025 Financial Results

August 14, 2025 | globenewswire.com

22nd Century Group to Announce Second Quarter 2025 Results on August 14, 2025

August 7, 2025 | globenewswire.com

22nd Century Announces First Shipments of Pinnacle VLN® Products to Top 5 C-Store Chain Locations Across 12 States

August 4, 2025 | globenewswire.com

22nd Century Group, Inc. Highlights FDA Authorization of VLN® Products as Compliant Reduced Nicotine Cigarettes

July 29, 2025 | quiverquant.comQ

22nd Century Applauds the American Academy of Family Physicians Comments and Support of the FDA's Proposed Reduced Nicotine Mandate to Reduce Smoking, Transform Public Health, Save Lives and Reduce Health Costs

July 29, 2025 | globenewswire.com

22nd Century Reports Expanded State Authorization Progress to Sell VLN®, Partner VLN® and Conventional Products

July 17, 2025 | globenewswire.com

VLN Commercial Launches Confirm Viability of the FDA’s Proposed Reduced Nicotine Mandate

July 17, 2025 | finance.yahoo.com

22nd Century Group stock soars after expanding VLN cigarette partnerships

July 17, 2025 | investing.com

22nd Century Group Stock Jumps 75% After Hour On News Of Reduced-Nicotine Push

July 17, 2025 | benzinga.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRWC, GRWG, NMUS, and XXII Company Descriptions

Grow Capital OTCMKTS:GRWC

$0.20 0.00 (0.00%)

As of 08/29/2025

Grow Capital, Inc. operates in the financial technology sector. It provides software, technology, and services to financial services firms and advisors. The company's software suite delivers customized back office compliance, multi-pay commission processing, and new client application submission system, as well as digital engagement marketing services centric to financial services. It also provides software customization, licensing, and subscription service contracts, as well as ongoing customization and maintenance services; and ad hoc services, including web hosting, website development, and other complementary professional services. The company was incorporated in 1999 and is based in Henderson, Nevada.

GrowGeneration NASDAQ:GRWG

$1.70 -0.07 (-3.95%)

Closing price 08/29/2025 04:00 PM Eastern

Extended Trading

$1.69 -0.01 (-0.59%)

As of 08/29/2025 07:45 PM Eastern

GrowGeneration Corp., through its subsidiaries, owns and operates retail hydroponic and organic gardening stores in the United States. The company engages in the marketing and distribution of nutrients, additives, growing media, lighting, and environmental control systems, as well as other indoor and outdoor growing products. It operates a chain of stores in California, Colorado, Michigan, Maine, Oklahoma, Oregon, Washington, Montana, New York, Ohio, Mississippi, Missouri, Arizona, Rhode Island, Florida, Massachusetts, Virginia, New Jersey, and New Mexico, as well as growgeneration.com, an online superstore for cultivators, a wholesale business for resellers, HRG Distribution, and benching, racking, and storage solutions and MMI. The company was formerly known as Easylife Corp. GrowGeneration Corp. was founded in 2008 and is based in Greenwood Village, Colorado.

Nemus Bioscience OTCMKTS:NMUS

Nemus Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics. The company's product candidates in preclinical stage include NB1111 for the treatment of glaucoma; NB1222 used for treating chemotherapy induced nausea and vomiting; and NB3111 for the treatment of methicillin-resistant staphylococcus aureus. Its products under research comprise NB2111 for use in treating chemotherapy induced peripheral neuropathy; and NB2222 for the treatment of uveitis, dry eye syndrome, macular degeneration, and diabetic retinopathy. Nemus Bioscience, Inc. has a license agreement with the University of Mississippi to research, develop, and commercialize products for the treatment of infectious diseases. The company was founded in 2012 and is headquartered in Costa Mesa, California.

22nd Century Group NASDAQ:XXII

$1.75 -0.05 (-2.78%)

Closing price 08/29/2025 04:00 PM Eastern

Extended Trading

$1.74 -0.01 (-0.51%)

As of 08/29/2025 07:46 PM Eastern

22nd Century Group, Inc., a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands. The company was founded in 1998 and is headquartered in Mocksville, North Carolina.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time